PMS experiences to be included in product monographs of two impotence medications

Published: 2013-03-11 06:59:00

Updated: 2013-03-11 06:59:00

The Korea Food and Drug Administration said Friday post-marketing surveillance (PMS) experiences reported by patients treated with Eli Lilly’s Cialis and Dong-A Pharmaceutical’s Zydena, oral therapy for the treatment of erectile dysfunction, will be added to the ‘precaution in use’ section of the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK